The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
Advanced Micro Devices shares fell Wednesday after HSBC analysts gave the stock a double downgrade, citing concerns about its artificial intelligence revenue.
HSBC lowered its rating on Advanced Micro Devices stock amid several concerns including the chipmaker's ability to compete ...
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
AMD’s stock just got downgraded, with HSBC warning that the company’s “AI GPU roadmap is less competitive than we previously ...
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Advanced Micro Devices lags Nvidia in AI design wins, prompting a downgrade to sell. See why AMD stock faces little room to ...
In the high-tech universe, there is a single common road that top-flight companies like Nvidia (NASDAQ: NVDA), Advanced Micro ...
In a note to clients on Sunday, Jefferies analyst Steven G. DeSanctis estimated that for 2025, the Sweet 16 would show an aggregate earnings increase of 21.5%, with a median increase of 15.8%. For the ...
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Advanced Micro Devices (NASDAQ: AMD) stock saw significant sell-offs in December's trading. The semiconductor company's share ...
华盛顿州温哥华 - 市值3.53亿美元的生成式AI药物创制公司Absci Corporation (NASDAQ: ABSI)宣布与Advanced Micro Devices, Inc. (AMD)达成战略合作,涉及2000万美元的股权投资,旨在增强AI驱动的药物发现能力。这项合作将利用AMD Instinct加速器和ROCm软件为Absci的AI模型提供动力,用于开发新的抗体疗法。根据 ...